Involvement of sting-activating cyclic Di-nucleotides on T-cell differentiation and function: An unresolved issue [Sting’i etkinleştiren siklik dinükleotidlerin T hücre diferansiyasyonu ve fonksiyonuna olan etkisi: Çözülmemiş bir sorun] by Yıldız B. & Gürsel İ.
Turk J Immunol 2016;4(3):47-51 Turkish Journal of Immunology - Open Access
Review / Derleme
www.turkishimmunology.org
Involvement of Sting-Activating Cyclic Di-Nucleotides on T-Cell 
Differentiation and Function: An Unresolved Issue
Sting’i Etkinleştiren Siklik Dinükleotidlerin T Hücre Diferansiyasyonu ve Fonksiyonuna Olan 
Etkisi: Çözülmemiş bir Sorun
Begüm Yıldız, İhsan Gürsel
Department of Molecular Biology 
and Genetics, Thorlab, Therapeutic 
Oligonucleotide Research Laboratory, 
Bilkent University, Ankara, Turkey
Correspondence:
İhsan Gürsel, MD.
Bilkent Üniversitesi, Thorlab, Moleküler 
Biyoloji ve Genetik Bölümü, Fen Fakültesi, 
06800 Bilkent, Ankara, Turkey
Tel: +90 312 - 290 24 08
e-mail: ihsangursel@bilkent.edu.tr
©2016 Turkish Journal of Immunology. 
All rights reserved. STING (Stimulator of interferon genes), hem patojen ve konağın kendi sitozolik çift sarmallı 
DNA (dsDNA)’sına hem de mikrop kaynaklı siklik di-nükleotidlerin tanınmasında önemli 
bir mediyatördür. Çalışmalar, kanser hücrelerinden salınan DNA’nın, makrofaj ve dendritik 
hücreler gibi doğal bağışıklık sistemi hücreleri tarafından tümör mikro çevresindeki hücrelerce 
alındığını göstermiştir. Bu internalizasyon STING’in tetiklediği yolak üzerinden interferon beta, 
interlökin 6, tümör nekroz faktör alfa ve interlökin 12 gibi diğer pro-enflamatuar sitokinlerin 
salımını yönlendirir. Daha sonra bu sitokinler interferon gama üretimini artırarak CD8+ 
T hücrelerinin sitotoksik etkinliklerini artırır. Bu derleme STING yolağının hücre içi patojenlere 
karşı oluşan immünitedeki rolünü ve T-hücreleri üzerine olası doğrudan etkilerini tartışmaktadır.
Anahtar sözcükler: Adjuvan; cGAMP; immün cevap; STING; T lenfositleri.
STING is the pivotal mediator for the recognition of host and pathogenic cytosolic dsDNA as well 
as cyclic di-nucleotide metabolites from microbes. Studies demonstrated that DNA released from 
cancerous cells are internalized by innate immune cells such as macrophages and dendritic cells in tumor 
microenvironment and trigger the production of interferon beta and other pro-inflammatory cytokines 
including  interleukin 6, tumor necrosis factor alpha, and interleukin 12 through STING triggered 
signaling pathway. Later, these cytokines increase the cytotoxic activity of CD8+ T-cells by increasing 
the production of interferon gamma. This review discusses the importance of the involvement of STING 
during the establishment of immunity against intracellular pathogens and its direct effect on T-cells.
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The general and main goal of the immune system are 
to guard the body from wide range of microorganism. 
During recognition and elimination of microbes, the 
first discernment mechanism is its ability to distinguish 
self from non-self. This ability provides the immune 
system to eradicate not only microbes but also toxins 
and allergens.[1] The immune system has two arms 
including innate and adaptive immunity. These two 
arms of the immune system implement the main 
mechanism, which is the discrimination of self from 
non-self to protect host from intruders and pathologic 
insult. The innate and adaptive immune systems are 
complementing each other during the combat with the 
insulting agent and relies on similar as well as distinct 
signaling mechanisms. Importantly, they differ in terms 
of rapidity and specificity of the response. The innate 
immune system is the first line of defense of the body 
and consists of both physical, chemical barriers and 
specific type of cells such as monocytes, macrophages, 
and neutrophils. The basic virtue of the innate immune 
system is an immediate defense.[2] The cells of the innate 
immune system react against pathogens at the same 
extent no matter how many times they encounter. On 
the other hand, adaptive immune system possesses the 
antigen specific response, which establishes antigen 
dependent specificity by T- and B-lymphocytes. In 
other words, the hallmark of adaptive immunity is 
an increased response in the presence of repeated 
infectious and the development of memory against 
specific antigens.[3]
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Innate immune system, which comprises of various 
types of cells including monocytes, dendritic cells, 
macrophages, neutrophils, basophils, eosinophils, 
mast cells and natural killer cells, provides the first 
and immediate response against pathogens. Although 
innate immune system does not have any capability 
to develop memory against specific type of antigens, 
the majority of infections that the host encounter are 
cleared by innate immune cells without any interaction 
with adaptive immunity. Innate immune system has 
three distinct phases to eliminate pathogens. In the 
first phases, physical barriers and soluble factors such 
as antimicrobial peptides or complement system are 
implemented for the clearance of pathogens. After 
releasing soluble factors upon microbes, pathogen-
sensing mechanisms are triggered by innate immune 
cells and gets activated. Pathogen associated molecular 
patterns (PAMPs) are molecules from pathogens that 
are sensed by the members of the innate immune 
system. They are recognized by pattern recognition 
receptors (PRRs) including Toll-like receptors (TLRs), 
Nucleotide oligomerization receptors (NLRs), C-type 
lectin receptors (CLRs) and RIG-1 like receptors (RLRs), 
AIM2 like receptors (ALRs) and cytosolic DNA sensors. 
As a third phase, specific type of innate immune cells 
called antigen presenting cells (APCs) present pathogen 
specific antigens to T lymphocytes for the expansion of 
antigen specific lymphocytes and long term memory.[4]
PATHOGEN SENSING MECHANISMS AND 
CYTOSOLIC DNA SENSORS
The pathogen sensing mechanism of innate immune 
system is mostly based on pattern recognition 
receptors (PRRs), which can identify the different 
part of pathogens. PRRs consist of different type of 
receptors including TLRs, NLRs, CLRs, RLRs, ALRs 
and cytosolic DNA sensors. They can be either at the 
cell surface or inside cell.[5] When pathogen associated 
molecules are sensed by PRRs, pro-inf lammatory 
cytokines or chemokines start to be secreted by 
innate immune cells by activating several signaling 
transduction pathways. Upon secretion of several 
cytokines and chemokines, other immune system 
members are recruited into the site of infection to 
strengthen the response.[6]
The recognition of pathogen-associated 
deoxyribonucleic acids (DNA) is the essential and 
spectacular mechanism by which innate immune cells 
detect microbes to trigger the second response for 
the protection. However, one of the most important 
criteria for this mechanism is the differentiation of self-
DNA and DNA from microbes. If this differentiation 
mechanism is interrupted, various types of autoimmune 
diseases arise. This is why the molecular mechanism of 
DNA sensors should be investigated and understood.[7]
There are several cytosolic DNA sensors including 
TLRs, ALRs and other DNA sensors. However, the 
major difference between TLRs and other cytosolic 
DNA sensors is the specificity of the sequence. TLR9 
only senses CpG motifs by inducing type I IFN response 
whereas other DNA sensors including AIM2, cGAS 
(Cyclic GMP-AMP synthase) and STING (Stimulator 
of interferon genes) recognize DNA in a sequence-
independent manner and provide huge amount of 
inflammatory cytokine secretion from innate immune 
cells. AIM2 is one of the cytosolic DNA sensors and leads 
to formation and oligomerization of the inflammasome 
complex by triggering caspase-1 cleavage and secretion 
of pro-inflammatory cytokines such as IL-1 beta and 
IL-18 unlike cGAS and STING.[8]
STING: THE CENTRAL SENSOR FOR TYPE-I 
INTERFERON SIGNALING
STING (Stimulator of interferon genes; also known 
as TMEM173, MPYS, MITA and ERIS) has a critical 
and central role as a DNA sensor since it can sense 
various types of pathogens such as bacteria and virus.[9] 
Moreover, recent studies showed that over-expression 
of STING causes severe autoimmune diseases. On the 
other hand, other studies demonstrated that it triggers 
activation of the adaptive immune cells in response to 
DNA vaccines.[10] Thus, understanding DNA sensing 
mechanism is crucial in terms of activation of innate 
and adaptive immune systems. STING is expressed 
mainly in the thymus, peripheral leukocytes, spleen, 
lung, heart and placenta but is poorly expressed in the 
brain, skeletal muscle, colon, small intestines, liver and 
kidney.[11,12]
cGAS is another key DNA sensor to boost both 
innate and adaptive immune systems in the presence of 
virus or bacteria. cGAS, which is an enzyme, recognizes 
dsDNA in cytosol in a sequence-independent manner 
and leads to secretion of type I interferon through 
STING pathway. Upon activation of cGAS by binding 
dsDNA, it converts cytosolic ATP and GTP to cyclic 
guanosine adenosine monophosphate (cGAMP). 
cGAMP activates STING signaling pathway by leading 
to type I interferon secretion.[13,14] Beside cGAS, other 
cytosolic proteins including DAI, DDX41, DNA-PK, 
and IFI16 recognize dsDNA and activate STING 
pathway resulting in e production of type I interferon.[15] 
Moreover, bacterial secondary metabolites such as cyclic 
di-GMP and cyclic di-AMP are sensed by DDX1 and 
STING activating signaling pathway leading to secretion 
of type I interferon.[16] Previous studies claimed that, 
upon STING activation through cyclic di-nucleotides 
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including cGAMP, c-di-GMP or c-di-AMP, other 
protein complexes or dsDNA, STING becomes activated 
and translocates from the ER. Although the exact 
mechanism remains unclear, Ishikawa and Barber[9] 
claimed that it goes to perinuclear vesicles by recruiting 
TBK1. STING-TBK1 complex phosphorylates IRF3 by 
providing its dimerization. Phosphorylated IRF3 goes to 
nucleus and binds to the promoter region of interferon 
beta by leading production of interferon beta and 
other co-regulated genes. Beside IRF3, STING-TBK1 
complex provides phosphorylation of STAT6 resulting 
in secretion of STAT6 dependent chemokines including 
CCL2, CCL20, and CCL26.[11,15]
Recent studies demonstrated that since STING 
activating cyclic di-nucleotides have an enormous 
potential to induce type I interferons and other 
inflammatory cytokines, they are of great importance 
against infections and cancer in terms of vaccine 
adjuvant therapies.[17-19] Li et al.[20] showed that innate 
immune cells including macrophages and dendritic 
cells from cGAS deficient mice failed to produce type I 
interferons and other related cytokines in the presence 
of virus infectious. They also demonstrated that cGAMP 
as an adjuvant boosts antigen specific T cells activation 
and antibody production in vivo. Beside infections, 
cyclic di-nucleotides become potential adjuvant for 
tumor immunotherapy. The study that was conducted 
by Woo et al.[21] pioneered to demonstrate the effect of 
STING signaling pathway in tumor microenvironment. 
When tumor-cell-derived DNA is released into 
environment, it is internalized by antigen presenting 
cells such as dendritic cells and trigger STING signaling 
pathway through cGAS-cGAMP-STING resulting in 
production of interferon beta and other inflammatory 
cytokines such as TNF-α, IL-6 and IL-12. These secreted 
cytokines provide an increase in CD8+ T cell priming 
against tumors via presenting tumor antigens.[21] As a 
result, they concluded that the host STING pathway 
is of capital importance for the mechanism of innate 
immune sensing of cancers and for the mechanism of 
destroying tumor cells. In the light of these findings, 
cyclic di-nucleotides such as cGAMP as STING ligands 
are considered to be critical vaccine adjuvants due to 
enhanced T cell priming capacity. Other studies focused 
on the investigation of in vivo immunotherapeutic 
potential of cyclic di-nucleotides. C-di-GMP was shown 
to induce interferon beta together with TNF-α, IL-6 and 
IL-12 in myeloid dendritic cells, RAW cell lines, mouse 
splenocytes and human PBMCs.[22-24] On the other hand, 
Yıldız et al.[25] showed that when c-di-GMP complexed 
with the cationic peptide nona-arginine, its uptake 
efficiency and the vaccine adjuvant activity increased. 
Furthermore, they increased the immunostimulatory 
activity of c-di-GMP by combining with the TLR9 
ligand, CpG oligodeoxynucleotide (CpG ODN). At the 
same time, another group combined K3 CpG and 
cGAMP and showed that this combination increased 
potency of type I adjuvant by providing a promising 
immunotherapeutic agent for cancer.[26] An important 
new study showed that the combination of cGAMP with 
chemotherapeutic agent 5-FU become a novel anti-tumor 
agent and has broad implications in immunotherapy.[27] 
As a result, cyclic di-nucleotides such as cGAMP become 
an important and effective vaccine adjuvant against 
intracellular pathogens and malignant cells. Although 
STING activating cyclic di-nucleotides are envisioned 
as novel and potent vaccine adjuvants, more thorough 
research is needed to unearth the mechanism of action 
of STING on different immune cells. Therefore, it will 
pave the way for the initiation of successful human 
trials.
EFFECT OF STING ACTIVATION ON T-CELL 
DIFFERENTIATION AND FUNCTION: AN 
UNIDENTIFIED ISSUE
The important criteria while developing vaccine 
adjuvants is the magnitude and quality of the immune 
response and its toxic side effects. To identify these, 
members of the both innate and adaptive immune 
system should be taken into account. However, previous 
studies merely focus on the function and effect of 
cGAMP in innate immune cells such as macrophages, 
monocytes and dendritic cells. However, to date there 
is no explicit study investigating the effect of STING 
signaling cascade on T-cells. There is only one abstract, 
which claims that STING deficiency increases expression 
of genes related with cytotoxic T lymphocytes.
Figure 1. cGAMP induces IL-17 secretion in Pan T cells. Pan T cells were 
stimulated with cGAMP for 3 days and IL-17 secretions were measured 
by ELISA p<0.05 (Begum Yildiz, MSc Thesis, Bilkent University, 2016, 

































On the other hand, our preliminary data showed that 
STING activation via cGAMP induces IL-17 secretion 
from Pan T cells (Figure 1). In the light of these 
preliminary findings we hypothesized that STING 
activation may lead to regulation of the development 
of several T cell subsets and this should be investigated.
Type I interferons (IFN-α/β) play a significant role 
not only in protection against viral infections but 
also in progression of bacterial infections, cancer and 
autoimmunity. Beside, they behave like a bridge between 
innate and adaptive immunity.[28] The activation of 
cytosolic receptors including TLRs, RLRs and cytosolic 
DNA sensors mostly result in secretion of type I 
interferons by inducing IRF pathway. Secretion of type 
I interferons enhances the activation of macrophages, 
B cell switching mechanism and the differentiation of 
helper T cells into Th1.[29] STING is the essential mediator 
for the recognition of cytosolic dsDNA, which triggers 
the production of type I interferon via TBK1-IRF3 
pathway. STING can recognize dsDNA directly or sense 
the cyclic dinucleotides secreted by pathogens. Beside, 
cytosolic ATP and GTP are converted into cGAMP upon 
DNA binding to cGAS enzyme and cGAMP interacts 
with STING and triggers the production of type I 
interferons, mostly IFN-β.[9,10] Since it has been shown 
that type I interferons are the key modulators to fight 
against bacterial, viral infections and malignancies, 
STING activating cyclic di-nucleotides such as cGAMP 
are thought to be effective candidates for vaccine 
adjuvants. Although they have an enormous potential 
as vaccine adjuvants, a great deal of research is needed 
in terms of immune response and cytotoxicity to initiate 
human clinical trials.[19] Nevertheless, studies performed 
so far have focused on the effect and the function of 
STING in innate immune system.
In conclusion, while many studies focus on the 
effect of STING in the presence of cyclic di-nucleotides 
on innate immune cells such as dendritic cells and 
macrophages we still have limited knowledge of the 
effect of STING on T lymphocytes. We believe that 
our first preliminary data implied that it might have a 
role in differentiation of T lymphocytes. This will not 
only disclose the function of STING on T lymphocyte 
differentiation and activation, but may also contribute 
to the efficiency of vaccine adjuvant therapies.
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